nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Abdominal pain—Sorafenib—liver cancer	0.00199	0.00217	CcSEcCtD
Indapamide—Body temperature increased—Sorafenib—liver cancer	0.00199	0.00217	CcSEcCtD
Indapamide—Dermatitis bullous—Epirubicin—liver cancer	0.00198	0.00216	CcSEcCtD
Indapamide—Purpura—Epirubicin—liver cancer	0.00197	0.00214	CcSEcCtD
Indapamide—Vascular purpura—Doxorubicin—liver cancer	0.00196	0.00214	CcSEcCtD
Indapamide—Hepatic failure—Doxorubicin—liver cancer	0.00195	0.00213	CcSEcCtD
Indapamide—Cerebrovascular accident—Epirubicin—liver cancer	0.00193	0.00211	CcSEcCtD
Indapamide—Lethargy—Epirubicin—liver cancer	0.00193	0.00211	CcSEcCtD
Indapamide—Hyponatraemia—Epirubicin—liver cancer	0.0019	0.00208	CcSEcCtD
Indapamide—Osteoarthritis—Epirubicin—liver cancer	0.00189	0.00207	CcSEcCtD
Indapamide—Increased appetite—Doxorubicin—liver cancer	0.00187	0.00204	CcSEcCtD
Indapamide—Migraine—Epirubicin—liver cancer	0.00186	0.00203	CcSEcCtD
Indapamide—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00186	0.00203	CcSEcCtD
Indapamide—Hypersensitivity—Sorafenib—liver cancer	0.00186	0.00203	CcSEcCtD
Indapamide—Dermatitis bullous—Doxorubicin—liver cancer	0.00183	0.002	CcSEcCtD
Indapamide—Face oedema—Epirubicin—liver cancer	0.00183	0.002	CcSEcCtD
Indapamide—Purpura—Doxorubicin—liver cancer	0.00182	0.00198	CcSEcCtD
Indapamide—Asthenia—Sorafenib—liver cancer	0.00181	0.00197	CcSEcCtD
Indapamide—Cerebrovascular accident—Doxorubicin—liver cancer	0.00179	0.00195	CcSEcCtD
Indapamide—Lethargy—Doxorubicin—liver cancer	0.00179	0.00195	CcSEcCtD
Indapamide—Pruritus—Sorafenib—liver cancer	0.00178	0.00195	CcSEcCtD
Indapamide—Ataxia—Epirubicin—liver cancer	0.00178	0.00194	CcSEcCtD
Indapamide—Dehydration—Epirubicin—liver cancer	0.00176	0.00192	CcSEcCtD
Indapamide—Hyponatraemia—Doxorubicin—liver cancer	0.00176	0.00192	CcSEcCtD
Indapamide—Osteoarthritis—Doxorubicin—liver cancer	0.00175	0.00191	CcSEcCtD
Indapamide—Liver function test abnormal—Epirubicin—liver cancer	0.00175	0.00191	CcSEcCtD
Indapamide—Orthostatic hypotension—Epirubicin—liver cancer	0.00173	0.00189	CcSEcCtD
Indapamide—Abdominal pain upper—Epirubicin—liver cancer	0.00173	0.00189	CcSEcCtD
Indapamide—Migraine—Doxorubicin—liver cancer	0.00173	0.00188	CcSEcCtD
Indapamide—Hypokalaemia—Epirubicin—liver cancer	0.00172	0.00188	CcSEcCtD
Indapamide—Diarrhoea—Sorafenib—liver cancer	0.00172	0.00188	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00171	0.00186	CcSEcCtD
Indapamide—Nasopharyngitis—Epirubicin—liver cancer	0.00169	0.00185	CcSEcCtD
Indapamide—Face oedema—Doxorubicin—liver cancer	0.00169	0.00185	CcSEcCtD
Indapamide—Gastritis—Epirubicin—liver cancer	0.00168	0.00183	CcSEcCtD
Indapamide—Muscular weakness—Epirubicin—liver cancer	0.00167	0.00182	CcSEcCtD
Indapamide—Dizziness—Sorafenib—liver cancer	0.00167	0.00182	CcSEcCtD
Indapamide—Ataxia—Doxorubicin—liver cancer	0.00165	0.0018	CcSEcCtD
Indapamide—Asthma—Epirubicin—liver cancer	0.00164	0.00179	CcSEcCtD
Indapamide—Influenza—Epirubicin—liver cancer	0.00164	0.00179	CcSEcCtD
Indapamide—Dysphagia—Epirubicin—liver cancer	0.00164	0.00179	CcSEcCtD
Indapamide—Dehydration—Doxorubicin—liver cancer	0.00163	0.00178	CcSEcCtD
Indapamide—Liver function test abnormal—Doxorubicin—liver cancer	0.00162	0.00177	CcSEcCtD
Indapamide—Pancreatitis—Epirubicin—liver cancer	0.00161	0.00175	CcSEcCtD
Indapamide—Vomiting—Sorafenib—liver cancer	0.0016	0.00175	CcSEcCtD
Indapamide—Abdominal pain upper—Doxorubicin—liver cancer	0.0016	0.00175	CcSEcCtD
Indapamide—Orthostatic hypotension—Doxorubicin—liver cancer	0.0016	0.00175	CcSEcCtD
Indapamide—Hypokalaemia—Doxorubicin—liver cancer	0.0016	0.00174	CcSEcCtD
Indapamide—Angina pectoris—Epirubicin—liver cancer	0.0016	0.00174	CcSEcCtD
Indapamide—Rash—Sorafenib—liver cancer	0.00159	0.00173	CcSEcCtD
Indapamide—Dermatitis—Sorafenib—liver cancer	0.00159	0.00173	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00158	0.00172	CcSEcCtD
Indapamide—Headache—Sorafenib—liver cancer	0.00158	0.00172	CcSEcCtD
Indapamide—Bronchitis—Epirubicin—liver cancer	0.00157	0.00172	CcSEcCtD
Indapamide—Nasopharyngitis—Doxorubicin—liver cancer	0.00157	0.00171	CcSEcCtD
Indapamide—Gastritis—Doxorubicin—liver cancer	0.00155	0.00169	CcSEcCtD
Indapamide—Muscular weakness—Doxorubicin—liver cancer	0.00155	0.00169	CcSEcCtD
Indapamide—Dysuria—Epirubicin—liver cancer	0.00153	0.00167	CcSEcCtD
Indapamide—Asthma—Doxorubicin—liver cancer	0.00152	0.00165	CcSEcCtD
Indapamide—Dysphagia—Doxorubicin—liver cancer	0.00152	0.00165	CcSEcCtD
Indapamide—Influenza—Doxorubicin—liver cancer	0.00152	0.00165	CcSEcCtD
Indapamide—Pollakiuria—Epirubicin—liver cancer	0.00151	0.00165	CcSEcCtD
Indapamide—Nausea—Sorafenib—liver cancer	0.0015	0.00163	CcSEcCtD
Indapamide—Photosensitivity reaction—Epirubicin—liver cancer	0.00149	0.00163	CcSEcCtD
Indapamide—Pancreatitis—Doxorubicin—liver cancer	0.00149	0.00162	CcSEcCtD
Indapamide—Weight decreased—Epirubicin—liver cancer	0.00148	0.00162	CcSEcCtD
Indapamide—Hyperglycaemia—Epirubicin—liver cancer	0.00148	0.00161	CcSEcCtD
Indapamide—Angina pectoris—Doxorubicin—liver cancer	0.00148	0.00161	CcSEcCtD
Indapamide—Pneumonia—Epirubicin—liver cancer	0.00147	0.0016	CcSEcCtD
Indapamide—Drowsiness—Epirubicin—liver cancer	0.00146	0.00159	CcSEcCtD
Indapamide—Bronchitis—Doxorubicin—liver cancer	0.00146	0.00159	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00145	0.00158	CcSEcCtD
Indapamide—Renal failure—Epirubicin—liver cancer	0.00144	0.00157	CcSEcCtD
Indapamide—Jaundice—Epirubicin—liver cancer	0.00142	0.00155	CcSEcCtD
Indapamide—Stomatitis—Epirubicin—liver cancer	0.00142	0.00155	CcSEcCtD
Indapamide—Urinary tract infection—Epirubicin—liver cancer	0.00142	0.00155	CcSEcCtD
Indapamide—Conjunctivitis—Epirubicin—liver cancer	0.00142	0.00155	CcSEcCtD
Indapamide—Dysuria—Doxorubicin—liver cancer	0.00142	0.00155	CcSEcCtD
Indapamide—Sweating—Epirubicin—liver cancer	0.0014	0.00153	CcSEcCtD
Indapamide—Pollakiuria—Doxorubicin—liver cancer	0.0014	0.00153	CcSEcCtD
Indapamide—Photosensitivity reaction—Doxorubicin—liver cancer	0.00138	0.00151	CcSEcCtD
Indapamide—Hepatobiliary disease—Epirubicin—liver cancer	0.00138	0.00151	CcSEcCtD
Indapamide—Weight decreased—Doxorubicin—liver cancer	0.00137	0.0015	CcSEcCtD
Indapamide—Sinusitis—Epirubicin—liver cancer	0.00137	0.00149	CcSEcCtD
Indapamide—Hyperglycaemia—Doxorubicin—liver cancer	0.00137	0.00149	CcSEcCtD
Indapamide—Agranulocytosis—Epirubicin—liver cancer	0.00136	0.00149	CcSEcCtD
Indapamide—Pneumonia—Doxorubicin—liver cancer	0.00136	0.00148	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—liver cancer	0.00135	0.00147	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00134	0.00146	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—liver cancer	0.00133	0.00145	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—liver cancer	0.00132	0.00144	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—liver cancer	0.00132	0.00144	CcSEcCtD
Indapamide—Rhinitis—Epirubicin—liver cancer	0.00131	0.00143	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—liver cancer	0.00131	0.00143	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—liver cancer	0.00131	0.00143	CcSEcCtD
Indapamide—Hepatitis—Epirubicin—liver cancer	0.00131	0.00143	CcSEcCtD
Indapamide—Hypoaesthesia—Epirubicin—liver cancer	0.0013	0.00142	CcSEcCtD
Indapamide—Pharyngitis—Epirubicin—liver cancer	0.0013	0.00142	CcSEcCtD
Indapamide—Sweating—Doxorubicin—liver cancer	0.0013	0.00141	CcSEcCtD
Indapamide—Urinary tract disorder—Epirubicin—liver cancer	0.00129	0.00141	CcSEcCtD
Indapamide—Oedema peripheral—Epirubicin—liver cancer	0.00129	0.00141	CcSEcCtD
Indapamide—Urethral disorder—Epirubicin—liver cancer	0.00128	0.0014	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—liver cancer	0.00128	0.00139	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—liver cancer	0.00127	0.00138	CcSEcCtD
Indapamide—Visual impairment—Epirubicin—liver cancer	0.00126	0.00138	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—liver cancer	0.00126	0.00138	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—liver cancer	0.00124	0.00135	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—liver cancer	0.00122	0.00133	CcSEcCtD
Indapamide—Flushing—Epirubicin—liver cancer	0.00122	0.00133	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—liver cancer	0.00122	0.00133	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—liver cancer	0.00122	0.00133	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—liver cancer	0.00121	0.00132	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—liver cancer	0.00121	0.00132	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—liver cancer	0.0012	0.00131	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—liver cancer	0.0012	0.00131	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—liver cancer	0.00119	0.0013	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—liver cancer	0.00119	0.0013	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—liver cancer	0.00117	0.00128	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—liver cancer	0.00117	0.00128	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—liver cancer	0.00115	0.00125	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—liver cancer	0.00114	0.00124	CcSEcCtD
Indapamide—Erythema—Epirubicin—liver cancer	0.00114	0.00124	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—liver cancer	0.00113	0.00123	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—liver cancer	0.00113	0.00123	CcSEcCtD
Indapamide—Flushing—Doxorubicin—liver cancer	0.00113	0.00123	CcSEcCtD
Indapamide—Flatulence—Epirubicin—liver cancer	0.00112	0.00123	CcSEcCtD
Indapamide—Tension—Epirubicin—liver cancer	0.00112	0.00122	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—liver cancer	0.00112	0.00122	CcSEcCtD
Indapamide—Nervousness—Epirubicin—liver cancer	0.00111	0.00121	CcSEcCtD
Indapamide—Back pain—Epirubicin—liver cancer	0.0011	0.0012	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—liver cancer	0.0011	0.0012	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—liver cancer	0.00108	0.00118	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—liver cancer	0.00108	0.00117	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—liver cancer	0.00106	0.00116	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—liver cancer	0.00106	0.00115	CcSEcCtD
Indapamide—Erythema—Doxorubicin—liver cancer	0.00106	0.00115	CcSEcCtD
Indapamide—Anaemia—Epirubicin—liver cancer	0.00105	0.00115	CcSEcCtD
Indapamide—Agitation—Epirubicin—liver cancer	0.00105	0.00114	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—liver cancer	0.00104	0.00114	CcSEcCtD
Indapamide—Tension—Doxorubicin—liver cancer	0.00104	0.00113	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—liver cancer	0.00103	0.00113	CcSEcCtD
Indapamide—Malaise—Epirubicin—liver cancer	0.00103	0.00112	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—liver cancer	0.00103	0.00112	CcSEcCtD
Indapamide—Vertigo—Epirubicin—liver cancer	0.00103	0.00112	CcSEcCtD
Indapamide—Syncope—Epirubicin—liver cancer	0.00102	0.00112	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—liver cancer	0.00102	0.00111	CcSEcCtD
Indapamide—Back pain—Doxorubicin—liver cancer	0.00102	0.00111	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—liver cancer	0.00101	0.00111	CcSEcCtD
Indapamide—Furosemide—ALB—liver cancer	0.00101	0.624	CrCbGaD
Indapamide—Palpitations—Epirubicin—liver cancer	0.00101	0.0011	CcSEcCtD
Indapamide—Loss of consciousness—Epirubicin—liver cancer	0.001	0.00109	CcSEcCtD
Indapamide—Cough—Epirubicin—liver cancer	0.000996	0.00109	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—liver cancer	0.000995	0.00109	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—liver cancer	0.00098	0.00107	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—liver cancer	0.000976	0.00106	CcSEcCtD
Indapamide—Chest pain—Epirubicin—liver cancer	0.000971	0.00106	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—liver cancer	0.000971	0.00106	CcSEcCtD
Indapamide—Myalgia—Epirubicin—liver cancer	0.000971	0.00106	CcSEcCtD
Indapamide—Agitation—Doxorubicin—liver cancer	0.00097	0.00106	CcSEcCtD
Indapamide—Anxiety—Epirubicin—liver cancer	0.000968	0.00106	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000965	0.00105	CcSEcCtD
Indapamide—Discomfort—Epirubicin—liver cancer	0.00096	0.00105	CcSEcCtD
Indapamide—Malaise—Doxorubicin—liver cancer	0.000952	0.00104	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—liver cancer	0.00095	0.00104	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—liver cancer	0.000948	0.00103	CcSEcCtD
Indapamide—Syncope—Doxorubicin—liver cancer	0.000947	0.00103	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—liver cancer	0.000945	0.00103	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—liver cancer	0.000933	0.00102	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—liver cancer	0.000931	0.00102	CcSEcCtD
Indapamide—Oedema—Epirubicin—liver cancer	0.000931	0.00102	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—liver cancer	0.000928	0.00101	CcSEcCtD
Indapamide—Infection—Epirubicin—liver cancer	0.000925	0.00101	CcSEcCtD
Indapamide—Cough—Doxorubicin—liver cancer	0.000921	0.00101	CcSEcCtD
Indapamide—Shock—Epirubicin—liver cancer	0.000916	0.001	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—liver cancer	0.000913	0.000996	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—liver cancer	0.000912	0.000995	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—liver cancer	0.000909	0.000992	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—liver cancer	0.000904	0.000987	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—liver cancer	0.0009	0.000982	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—liver cancer	0.000899	0.000981	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—liver cancer	0.000899	0.000981	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—liver cancer	0.000899	0.000981	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—liver cancer	0.000896	0.000977	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000893	0.000974	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—liver cancer	0.000888	0.000969	CcSEcCtD
Indapamide—Anorexia—Epirubicin—liver cancer	0.000888	0.000969	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—liver cancer	0.000879	0.000959	CcSEcCtD
Indapamide—Hypotension—Epirubicin—liver cancer	0.00087	0.000949	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—liver cancer	0.000862	0.00094	CcSEcCtD
Indapamide—Oedema—Doxorubicin—liver cancer	0.000862	0.00094	CcSEcCtD
Indapamide—Infection—Doxorubicin—liver cancer	0.000856	0.000934	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000848	0.000926	CcSEcCtD
Indapamide—Shock—Doxorubicin—liver cancer	0.000848	0.000925	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—liver cancer	0.000845	0.000922	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—liver cancer	0.000844	0.000921	CcSEcCtD
Indapamide—Insomnia—Epirubicin—liver cancer	0.000842	0.000919	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—liver cancer	0.000841	0.000918	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—liver cancer	0.000837	0.000913	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—liver cancer	0.000836	0.000912	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—liver cancer	0.000833	0.000909	CcSEcCtD
Indapamide—Dyspnoea—Epirubicin—liver cancer	0.00083	0.000906	CcSEcCtD
Indapamide—Somnolence—Epirubicin—liver cancer	0.000828	0.000903	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—liver cancer	0.000821	0.000896	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—liver cancer	0.00082	0.000894	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—liver cancer	0.000809	0.000883	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—liver cancer	0.000805	0.000879	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000804	0.000877	CcSEcCtD
Indapamide—Fatigue—Epirubicin—liver cancer	0.000803	0.000876	CcSEcCtD
Indapamide—Constipation—Epirubicin—liver cancer	0.000796	0.000869	CcSEcCtD
Indapamide—Pain—Epirubicin—liver cancer	0.000796	0.000869	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000785	0.000857	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—liver cancer	0.000779	0.00085	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—liver cancer	0.000774	0.000844	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—liver cancer	0.000768	0.000838	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—liver cancer	0.000767	0.000837	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—liver cancer	0.000766	0.000836	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—liver cancer	0.000761	0.000831	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—liver cancer	0.000758	0.000828	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—liver cancer	0.000749	0.000817	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000744	0.000812	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—liver cancer	0.000743	0.000811	CcSEcCtD
Indapamide—Urticaria—Epirubicin—liver cancer	0.00074	0.000807	CcSEcCtD
Indapamide—Pain—Doxorubicin—liver cancer	0.000737	0.000804	CcSEcCtD
Indapamide—Constipation—Doxorubicin—liver cancer	0.000737	0.000804	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—liver cancer	0.000736	0.000803	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—liver cancer	0.000736	0.000803	CcSEcCtD
Indapamide—Feeling abnormal—Doxorubicin—liver cancer	0.00071	0.000775	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000705	0.000769	CcSEcCtD
Indapamide—Hypersensitivity—Epirubicin—liver cancer	0.000686	0.000749	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—liver cancer	0.000684	0.000747	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—liver cancer	0.000681	0.000743	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—liver cancer	0.000681	0.000743	CcSEcCtD
Indapamide—Asthenia—Epirubicin—liver cancer	0.000668	0.000729	CcSEcCtD
Indapamide—Pruritus—Epirubicin—liver cancer	0.000659	0.000719	CcSEcCtD
Indapamide—Diarrhoea—Epirubicin—liver cancer	0.000637	0.000695	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—liver cancer	0.000635	0.000693	CcSEcCtD
Indapamide—Asthenia—Doxorubicin—liver cancer	0.000618	0.000675	CcSEcCtD
Indapamide—Dizziness—Epirubicin—liver cancer	0.000616	0.000672	CcSEcCtD
Indapamide—Oxcarbazepine—ALB—liver cancer	0.000611	0.376	CrCbGaD
Indapamide—Pruritus—Doxorubicin—liver cancer	0.00061	0.000665	CcSEcCtD
Indapamide—Vomiting—Epirubicin—liver cancer	0.000592	0.000646	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—liver cancer	0.00059	0.000643	CcSEcCtD
Indapamide—Rash—Epirubicin—liver cancer	0.000587	0.000641	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—liver cancer	0.000587	0.00064	CcSEcCtD
Indapamide—Headache—Epirubicin—liver cancer	0.000583	0.000637	CcSEcCtD
Indapamide—Dizziness—Doxorubicin—liver cancer	0.00057	0.000622	CcSEcCtD
Indapamide—Nausea—Epirubicin—liver cancer	0.000553	0.000604	CcSEcCtD
Indapamide—Vomiting—Doxorubicin—liver cancer	0.000548	0.000598	CcSEcCtD
Indapamide—Rash—Doxorubicin—liver cancer	0.000543	0.000593	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—liver cancer	0.000543	0.000592	CcSEcCtD
Indapamide—Headache—Doxorubicin—liver cancer	0.00054	0.000589	CcSEcCtD
Indapamide—Nausea—Doxorubicin—liver cancer	0.000512	0.000558	CcSEcCtD
Indapamide—CA2—Metabolism—CPT1B—liver cancer	0.00019	0.00232	CbGpPWpGaD
Indapamide—CA2—Metabolism—GLUL—liver cancer	0.00019	0.00232	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00019	0.00232	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTA3—liver cancer	0.000188	0.0023	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HPGDS—liver cancer	0.000185	0.00226	CbGpPWpGaD
Indapamide—CA12—Metabolism—CRABP1—liver cancer	0.000183	0.00224	CbGpPWpGaD
Indapamide—CA2—Metabolism—NR1H4—liver cancer	0.000183	0.00224	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTA3—liver cancer	0.00018	0.0022	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—HRAS—liver cancer	0.000176	0.00215	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HPGDS—liver cancer	0.000173	0.00211	CbGpPWpGaD
Indapamide—CA7—Metabolism—HPGDS—liver cancer	0.000173	0.00211	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTA4—liver cancer	0.000172	0.0021	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000171	0.00209	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.00017	0.00207	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTA2—liver cancer	0.000168	0.00205	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PSMA4—liver cancer	0.000165	0.00202	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PSMD10—liver cancer	0.000165	0.00202	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTA4—liver cancer	0.000165	0.00201	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000165	0.00201	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTA1—liver cancer	0.000162	0.00197	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GOT2—liver cancer	0.000161	0.00196	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTA2—liver cancer	0.000161	0.00196	CbGpPWpGaD
Indapamide—CA9—Metabolism—GLUL—liver cancer	0.00016	0.00196	CbGpPWpGaD
Indapamide—CA12—Metabolism—HPGDS—liver cancer	0.00016	0.00196	CbGpPWpGaD
Indapamide—CA9—Metabolism—CPT1B—liver cancer	0.00016	0.00196	CbGpPWpGaD
Indapamide—CA4—Metabolism—NAT2—liver cancer	0.00016	0.00195	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN2A—liver cancer	0.00016	0.00195	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000156	0.00191	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTA1—liver cancer	0.000155	0.00189	CbGpPWpGaD
Indapamide—CA9—Metabolism—NR1H4—liver cancer	0.000155	0.00189	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PSMD10—liver cancer	0.000154	0.00188	CbGpPWpGaD
Indapamide—CA7—Metabolism—PSMD10—liver cancer	0.000154	0.00188	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PSMA4—liver cancer	0.000154	0.00188	CbGpPWpGaD
Indapamide—CA7—Metabolism—PSMA4—liver cancer	0.000154	0.00188	CbGpPWpGaD
Indapamide—CA2—Metabolism—NAT2—liver cancer	0.000153	0.00187	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALDOB—liver cancer	0.000153	0.00187	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000152	0.00186	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTA3—liver cancer	0.000152	0.00186	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP2E1—liver cancer	0.000151	0.00184	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MTOR—liver cancer	0.000151	0.00184	CbGpPWpGaD
Indapamide—CA7—Metabolism—GOT2—liver cancer	0.00015	0.00183	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GOT2—liver cancer	0.00015	0.00183	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.00015	0.00183	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000148	0.0018	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALDOB—liver cancer	0.000147	0.00179	CbGpPWpGaD
Indapamide—CA4—Metabolism—CRABP1—liver cancer	0.000146	0.00179	CbGpPWpGaD
Indapamide—CA12—Metabolism—PSMA4—liver cancer	0.000143	0.00174	CbGpPWpGaD
Indapamide—CA12—Metabolism—PSMD10—liver cancer	0.000143	0.00174	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN1B—liver cancer	0.000141	0.00173	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYCS—liver cancer	0.000141	0.00173	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP2E1—liver cancer	0.000141	0.00172	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP2E1—liver cancer	0.000141	0.00172	CbGpPWpGaD
Indapamide—CA2—Metabolism—CRABP1—liver cancer	0.00014	0.00171	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTA4—liver cancer	0.000139	0.0017	CbGpPWpGaD
Indapamide—CA12—Metabolism—GOT2—liver cancer	0.000139	0.0017	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GOT1—liver cancer	0.000139	0.00169	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GGT1—liver cancer	0.000139	0.00169	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000138	0.00169	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000137	0.00167	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000137	0.00167	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTA2—liver cancer	0.000135	0.00165	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000135	0.00165	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—JUN—liver cancer	0.000135	0.00164	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000133	0.00163	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYCS—liver cancer	0.000132	0.00161	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYCS—liver cancer	0.000132	0.00161	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP2E1—liver cancer	0.000131	0.0016	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTA1—liver cancer	0.000131	0.0016	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN1A—liver cancer	0.000131	0.00159	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GOT1—liver cancer	0.00013	0.00158	CbGpPWpGaD
Indapamide—CA7—Metabolism—GGT1—liver cancer	0.00013	0.00158	CbGpPWpGaD
Indapamide—CA7—Metabolism—GOT1—liver cancer	0.00013	0.00158	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GGT1—liver cancer	0.00013	0.00158	CbGpPWpGaD
Indapamide—CA9—Metabolism—NAT2—liver cancer	0.000129	0.00158	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000129	0.00157	CbGpPWpGaD
Indapamide—CA4—Metabolism—HPGDS—liver cancer	0.000128	0.00156	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK8—liver cancer	0.000127	0.00156	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000127	0.00155	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ALB—liver cancer	0.000126	0.00154	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000125	0.00153	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTP1—liver cancer	0.000125	0.00152	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALDOB—liver cancer	0.000124	0.00151	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HMOX1—liver cancer	0.000123	0.0015	CbGpPWpGaD
Indapamide—CA2—Metabolism—HPGDS—liver cancer	0.000123	0.0015	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYCS—liver cancer	0.000122	0.00149	CbGpPWpGaD
Indapamide—CA12—Metabolism—GOT1—liver cancer	0.00012	0.00146	CbGpPWpGaD
Indapamide—CA12—Metabolism—GGT1—liver cancer	0.00012	0.00146	CbGpPWpGaD
Indapamide—CA9—Metabolism—CRABP1—liver cancer	0.000118	0.00144	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—liver cancer	0.000118	0.00144	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—STAT3—liver cancer	0.000117	0.00142	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTP1—liver cancer	0.000116	0.00142	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTP1—liver cancer	0.000116	0.00142	CbGpPWpGaD
Indapamide—CA7—Metabolism—HMOX1—liver cancer	0.000115	0.0014	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HMOX1—liver cancer	0.000115	0.0014	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTM1—liver cancer	0.000115	0.0014	CbGpPWpGaD
Indapamide—CA4—Metabolism—PSMA4—liver cancer	0.000114	0.00139	CbGpPWpGaD
Indapamide—CA4—Metabolism—PSMD10—liver cancer	0.000114	0.00139	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000114	0.00139	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000112	0.00137	CbGpPWpGaD
Indapamide—CA4—Metabolism—GOT2—liver cancer	0.000111	0.00135	CbGpPWpGaD
Indapamide—CA2—Metabolism—PSMA4—liver cancer	0.000109	0.00133	CbGpPWpGaD
Indapamide—CA2—Metabolism—PSMD10—liver cancer	0.000109	0.00133	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP1A1—liver cancer	0.000109	0.00133	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTP1—liver cancer	0.000108	0.00132	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTM1—liver cancer	0.000107	0.00131	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTM1—liver cancer	0.000107	0.00131	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000107	0.0013	CbGpPWpGaD
Indapamide—CA12—Metabolism—HMOX1—liver cancer	0.000106	0.0013	CbGpPWpGaD
Indapamide—CA2—Metabolism—GOT2—liver cancer	0.000106	0.0013	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP2E1—liver cancer	0.000104	0.00127	CbGpPWpGaD
Indapamide—CA9—Metabolism—HPGDS—liver cancer	0.000103	0.00126	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000102	0.00124	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1A1—liver cancer	0.000101	0.00124	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1A1—liver cancer	0.000101	0.00124	CbGpPWpGaD
Indapamide—CA5A—Metabolism—MTHFR—liver cancer	0.000101	0.00124	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP2E1—liver cancer	9.99e-05	0.00122	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARA—liver cancer	9.93e-05	0.00121	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTM1—liver cancer	9.91e-05	0.00121	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYCS—liver cancer	9.75e-05	0.00119	CbGpPWpGaD
Indapamide—CA4—Metabolism—GOT1—liver cancer	9.57e-05	0.00117	CbGpPWpGaD
Indapamide—CA4—Metabolism—GGT1—liver cancer	9.57e-05	0.00117	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MTHFR—liver cancer	9.45e-05	0.00115	CbGpPWpGaD
Indapamide—CA7—Metabolism—MTHFR—liver cancer	9.45e-05	0.00115	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1A1—liver cancer	9.39e-05	0.00115	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYCS—liver cancer	9.35e-05	0.00114	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARA—liver cancer	9.27e-05	0.00113	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARA—liver cancer	9.27e-05	0.00113	CbGpPWpGaD
Indapamide—CA9—Metabolism—PSMD10—liver cancer	9.21e-05	0.00112	CbGpPWpGaD
Indapamide—CA9—Metabolism—PSMA4—liver cancer	9.21e-05	0.00112	CbGpPWpGaD
Indapamide—CA2—Metabolism—GGT1—liver cancer	9.18e-05	0.00112	CbGpPWpGaD
Indapamide—CA2—Metabolism—GOT1—liver cancer	9.18e-05	0.00112	CbGpPWpGaD
Indapamide—CA9—Metabolism—GOT2—liver cancer	8.96e-05	0.00109	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—liver cancer	8.89e-05	0.00109	CbGpPWpGaD
Indapamide—CA12—Metabolism—MTHFR—liver cancer	8.76e-05	0.00107	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—liver cancer	8.6e-05	0.00105	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARA—liver cancer	8.59e-05	0.00105	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CG—liver cancer	8.51e-05	0.00104	CbGpPWpGaD
Indapamide—CA4—Metabolism—HMOX1—liver cancer	8.48e-05	0.00103	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2E1—liver cancer	8.42e-05	0.00103	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP2E1—liver cancer	8.29e-05	0.00101	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—liver cancer	8.24e-05	0.00101	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARG—liver cancer	8.21e-05	0.001	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	8.18e-05	0.000998	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IL6—liver cancer	8.14e-05	0.000993	CbGpPWpGaD
Indapamide—CA2—Metabolism—HMOX1—liver cancer	8.13e-05	0.000992	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CG—liver cancer	7.94e-05	0.000969	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CG—liver cancer	7.94e-05	0.000969	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—liver cancer	7.9e-05	0.000964	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYCS—liver cancer	7.88e-05	0.000962	CbGpPWpGaD
Indapamide—CA9—Metabolism—GOT1—liver cancer	7.73e-05	0.000944	CbGpPWpGaD
Indapamide—CA9—Metabolism—GGT1—liver cancer	7.73e-05	0.000944	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARG—liver cancer	7.66e-05	0.000935	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARG—liver cancer	7.66e-05	0.000935	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GGT1—liver cancer	7.61e-05	0.000929	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—liver cancer	7.57e-05	0.000925	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1A1—liver cancer	7.49e-05	0.000914	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CD—liver cancer	7.48e-05	0.000913	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALB—liver cancer	7.38e-05	0.000901	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CG—liver cancer	7.36e-05	0.000898	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1A1—liver cancer	7.18e-05	0.000876	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARG—liver cancer	7.1e-05	0.000867	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTHFR—liver cancer	6.98e-05	0.000852	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CD—liver cancer	6.98e-05	0.000852	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CD—liver cancer	6.98e-05	0.000852	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—liver cancer	6.95e-05	0.000848	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALB—liver cancer	6.89e-05	0.000841	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALB—liver cancer	6.89e-05	0.000841	CbGpPWpGaD
Indapamide—CA9—Metabolism—HMOX1—liver cancer	6.85e-05	0.000836	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARA—liver cancer	6.85e-05	0.000836	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—liver cancer	6.84e-05	0.000835	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	6.74e-05	0.000823	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTHFR—liver cancer	6.69e-05	0.000817	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARA—liver cancer	6.57e-05	0.000802	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CB—liver cancer	6.52e-05	0.000796	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CD—liver cancer	6.47e-05	0.000789	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—liver cancer	6.38e-05	0.000779	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALB—liver cancer	6.38e-05	0.000779	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTM1—liver cancer	6.28e-05	0.000767	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	6.2e-05	0.000757	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CB—liver cancer	6.08e-05	0.000743	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CB—liver cancer	6.08e-05	0.000743	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1A1—liver cancer	6.05e-05	0.000739	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.96e-05	0.000727	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.88e-05	0.000717	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CG—liver cancer	5.87e-05	0.000716	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARG—liver cancer	5.66e-05	0.000691	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTHFR—liver cancer	5.64e-05	0.000689	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CB—liver cancer	5.64e-05	0.000688	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CG—liver cancer	5.62e-05	0.000687	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARA—liver cancer	5.54e-05	0.000676	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARG—liver cancer	5.43e-05	0.000663	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CD—liver cancer	5.16e-05	0.000629	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALB—liver cancer	5.09e-05	0.000621	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CD—liver cancer	4.94e-05	0.000604	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALB—liver cancer	4.88e-05	0.000596	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CG—liver cancer	4.74e-05	0.000579	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARG—liver cancer	4.58e-05	0.000558	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CB—liver cancer	4.5e-05	0.000549	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UGDH—liver cancer	4.46e-05	0.000544	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CB—liver cancer	4.31e-05	0.000526	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—EPT1—liver cancer	4.19e-05	0.000511	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CD—liver cancer	4.17e-05	0.000509	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALB—liver cancer	4.11e-05	0.000502	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—liver cancer	3.97e-05	0.000485	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TAT—liver cancer	3.97e-05	0.000485	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—liver cancer	3.71e-05	0.000453	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—liver cancer	3.71e-05	0.000453	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CB—liver cancer	3.63e-05	0.000443	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—liver cancer	3.44e-05	0.000419	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—liver cancer	3.25e-05	0.000396	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—liver cancer	3.03e-05	0.00037	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—liver cancer	3.03e-05	0.00037	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—liver cancer	2.81e-05	0.000343	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—liver cancer	2.74e-05	0.000334	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GLUL—liver cancer	2.7e-05	0.00033	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CPT1B—liver cancer	2.7e-05	0.00033	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—liver cancer	2.63e-05	0.000321	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NR1H4—liver cancer	2.6e-05	0.000318	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA3—liver cancer	2.56e-05	0.000312	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA4—liver cancer	2.34e-05	0.000286	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA2—liver cancer	2.28e-05	0.000278	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—liver cancer	2.24e-05	0.000273	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—liver cancer	2.21e-05	0.00027	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA1—liver cancer	2.2e-05	0.000269	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAT2—liver cancer	2.18e-05	0.000266	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—liver cancer	2.15e-05	0.000262	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDOB—liver cancer	2.09e-05	0.000255	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CRABP1—liver cancer	1.99e-05	0.000243	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—liver cancer	1.81e-05	0.000221	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPGDS—liver cancer	1.74e-05	0.000212	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSMA4—liver cancer	1.55e-05	0.000189	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSMD10—liver cancer	1.55e-05	0.000189	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GOT2—liver cancer	1.51e-05	0.000184	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2E1—liver cancer	1.42e-05	0.000173	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYCS—liver cancer	1.33e-05	0.000162	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GGT1—liver cancer	1.3e-05	0.000159	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GOT1—liver cancer	1.3e-05	0.000159	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—liver cancer	1.17e-05	0.000143	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMOX1—liver cancer	1.15e-05	0.000141	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—liver cancer	1.07e-05	0.000131	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1A1—liver cancer	1.02e-05	0.000124	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—liver cancer	9.5e-06	0.000116	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARA—liver cancer	9.32e-06	0.000114	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CG—liver cancer	7.98e-06	9.74e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARG—liver cancer	7.7e-06	9.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CD—liver cancer	7.02e-06	8.56e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALB—liver cancer	6.93e-06	8.45e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CB—liver cancer	6.11e-06	7.46e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—liver cancer	3.73e-06	4.55e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—liver cancer	3.05e-06	3.72e-05	CbGpPWpGaD
